Abbott Laboratories (ABT)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:59AM EDT. Market open.
| Previous close | 105.90 |
| Open | 106.50 |
| Bid | 105.66 x 1300 |
| Ask | 105.69 x 800 |
| Day's range | 105.45 - 107.03 |
| 52-week range | 89.67 - 121.64 |
| Volume | |
| Avg. volume | 5,858,533 |
| Market cap | 183.14B |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | 32.38 |
| EPS (TTM) | 3.26 |
| Earnings date | 18 Jul 2024 - 22 Jul 2024 |
| Forward dividend & yield | 2.20 (2.08%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | 126.59 |
Insider MonkeyAbbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript April 17, 2024 Abbott Laboratories isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Robert Ford – Chairman and Chief Executive Officer: Phil Boudreau – Senior Vice President, Finance and Chief Financial Officer: Bob […]
Simply Wall St.Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations
Abbott Laboratories ( NYSE:ABT ) First Quarter 2024 Results Key Financial Results Revenue: US$9.96b (up 2.2% from 1Q...
- GuruFocus.com
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations ...
Abbott Laboratories reports robust Q1 performance with significant sales growth and upward revisions in annual forecasts.
© 2024 Yahoo. All rights reserved.